The rejection that defies antirejection drugs—chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity

Vladimir M. Subbotin, Michael V. Subotin

Open source

DOI
10.1016/j.drudis.2024.104202
Published
2024-12
Container
Drug Discovery Today
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2024.104202,
  title = {The rejection that defies antirejection drugs—chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity},
  author = {Vladimir M. Subbotin and Michael V. Subotin},
  year = {2024},
  journal = {Drug Discovery Today},
  doi = {10.1016/j.drudis.2024.104202},
  url = {https://doi.org/10.1016/j.drudis.2024.104202}
}

RIS

TY  - JOUR
TI  - The rejection that defies antirejection drugs—chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity
AU  - Vladimir M. Subbotin
AU  - Michael V. Subotin
PY  - 2024
JO  - Drug Discovery Today
DO  - 10.1016/j.drudis.2024.104202
UR  - https://doi.org/10.1016/j.drudis.2024.104202
ER  - 

APA

Subbotin, V. M., & Subotin, M. V. (2024). The rejection that defies antirejection drugs—chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2024.104202

Source records